StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1475.HK$6.97-0.99%
Fair $6.97+0.0%

1475.HK

Nissin Foods Company Limited

Consumer Defensive / Packaged FoodsHKSE

$6.97

-0.07 (-0.99%)

Fairly Valued+0.0%Fair Value $6.97Fund rank 37/100 · Data gapFallback financials|
SA 44/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $322.4M · quality 81.0/100

Data gap 37/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 76/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 1475.HKLocal privado en este navegador · Nissin Foods Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$7.3B

P/E

21.8x

↑

EV/EBITDA

11.7x

↑

ROE

8.7%

↑

Gross Margin

34.6%

↑

Debt/Equity

0.00

↓
52-Week Range$7
$6$10

TradingView lightweight chart

1475.HK price, volumen y niveles de valoración

Último $6.970Periodo +106.8%
Fair value: $6.970

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-0.5%

FCF CAGR

+21.0%

FCF margin

9.2%

FCF / Net income

1.11x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.00B · net income $331.4M · FCF $367.7M

2022-FY → 2025-FY

Gross margin

34.6%+2.6% pts

Operating margin

12.2%+0.2% pts

Net margin

8.3%+0.6% pts

FCF margin

9.2%+4.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$4.00B$4.00B$3.81B$3.83B$4.07B
Net Income$331.4M$331.4M$201.0M$330.2M$312.8M
EBITDA$491.2M$491.2M$344.8M$504.9M$509.1M
EPS——0.190.320.30
Gross Margin34.6%34.6%34.4%34.0%32.0%
Operating Margin12.2%12.2%12.2%12.7%12.1%
Net Margin8.3%8.3%5.3%8.6%7.7%
Balance Sheet
Debt/Equity0.000.000.000.000.00
Current Ratio3.073.07———
Cash Flow
Free Cash Flow$367.7M$367.7M$315.7M$322.4M$207.4M
Returns
ROE8.7%8.7%5.6%9.1%8.8%
Valuation
P/E21.7821.7830.4819.1922.36
EV/EBITDA11.7411.7414.6010.1911.28
P/B1.901.901.691.741.97
Growth & Yield
Revenue Growth5.0%5.0%-0.6%-5.8%—
EPS Growth——-39.1%5.6%—
Dividend Yield2.3%2.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +4.8%

Total return

+4.8%

Start / end P/E

n/dx → n/dx

EPS bridge

0.19 → n/d

Residual

+2.5%

EPS growthn/d
Multiple reratingn/d
Dividend+2.3%
Residual / FX / buybacks / cross-term+2.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.